Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: Case report and review of the literature on response to tyrosine kinase inhibitors

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 3, 2009, Pages 635-640

  Skubitz, Keith M ^a   Manivel, J Carlos ^a   Clohisy, Denis R ^a   Frolich, Jerry W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Cancer; Chemotherapy; Desmoid; Fibromatosis; Imatinib; Sarcoma; Sunitinib; Tyrosine kinase; VEGF

Indexed keywords

DOXORUBICIN; ESCITALOPRAM; ETOPOSIDE; HYDROCHLOROTHIAZIDE; IFOSFAMIDE; IMATINIB; LANSOPRAZOLE; LEVOTHYROXINE; METHOTREXATE; METOPROLOL; OPIATE; ORAL CONTRACEPTIVE AGENT; PROTEIN TYROSINE KINASE INHIBITOR; SUNITINIB; VINBLASTINE; WARFARIN;

ADULT; AGEUSIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DESMOID TUMOR; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FIBROMATOSIS; GLUTEUS MAXIMUS MUSCLE; HAIR DISCOLORATION; HUMAN; HUMAN TISSUE; HYPERTENSION; KNEE FUNCTION; LEG; MOUTH ULCER; MUCOCUTANEOUS TOXICITY; MULTIPLE CYCLE TREATMENT; PAIN; PRIORITY JOURNAL; SIDE EFFECT; SKIN ULCER; THYROTROPIN BLOOD LEVEL; TREATMENT RESPONSE; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG RESISTANCE, NEOPLASM; FEMALE; FIBROMATOSIS, AGGRESSIVE; FOLLOW-UP STUDIES; HUMANS; INDOLES; NEOPLASM RECURRENCE, LOCAL; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; PYRROLES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349130222     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1010-0     Document Type: Article

References (40)

1. BA Alman DA Greel LK Ruby MJ Goldberg HJ Wolfe 1996 Regulation of proliferation and platelet-derived growth factor expression in palmar fibromatosis (Dupuytren contracture) by mechanical strain J Orthop Res 14 722 728 (Pubitemid 26376515)
2. BA Alman C Li ME Pajerski S Diaz-Cano HJ Wolfe 1997 Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors) Am J Pathol 151 329 334 (Pubitemid 27330053)
3. BA Alman ME Pajerski S Diaz-Cano K Corboy HJ Wolfe 1997 Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder Diagn Mol Pathol 6 98 101 (Pubitemid 27155030)
4. L Bertario A Russo P Sala M Eboli M Giarola F D'Amico V Gismondi L Varesco MA Pierotti P Radice 2001 Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis Int J Cancer 95 102 107 (Pubitemid 32187081)
5. PK Bhama R Chugh LH Baker GM Doherty 2006 Gardner's syndrome in a 40-year-old woman: successful treatment of locally aggressive desmoid tumors with cytotoxic chemotherapy World J Surg Oncol 4 96
6. PJ Bus HW Verspaget JH van Krieken A de Roos HJ Keizer WA Bemelman HF Vasen CB Lamers G Griffioen 1999 Treatment of mesenteric desmoid tumours with the anti-oestrogenic agent toremifene: case histories and an overview of the literature Eur J Gastroenterol Hepatol 11 1179 1183 (Pubitemid 30433772)
7. SS Cheon AY Cheah S Turley P Nadesan R Poon H Clevers BA Alman 2002 Beta-catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds Proc Natl Acad Sci USA 99 6973 6978 (Pubitemid 34526242)
8. J Couture A Mitri R Lagace R Smits T Berk HL Bouchard R Fodde B Alman B Bapat 2000 A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor Clin Genet 57 205 212 (Pubitemid 30168748)
9. CR de Andrade P Cotrin E Graner OP Almeida JJ Sauk RD Coletta 2001 Transforming growth factor-beta1 autocrine stimulation regulates fibroblast proliferation in hereditary gingival fibromatosis J Periodontol 72 1726 1733 (Pubitemid 34092739)
10. Farmer KC, Hawley PR, Phillips RK (1994) Desmoid disease. In: Phillips RK, Spigelman AD, Thompson JP (eds) Familial adenomatous polyposis and other polyposis syndromes. Edward Arnold, London, pp 128-142
11. F Folli G Galimberti M Pastore AM Davalli E Bosi 2006 Paraneoplastic insulin resistance syndrome in advanced aggressive fibromatosis (desmoid tumor) treated by imatinib mesylate Diabetes Care 29 2178 2180 (Pubitemid 44871210)
12. C Gebert J Hardes C Kersting C August H Supper W Winkelmann H Buerger G Gosheger 2007 Expression of beta-catenin and p53 are prognostic factors in deep aggressive fibromatosis Histopathology 50 491 497 (Pubitemid 46328180)
13. M Gega H Yanagi R Yoshikawa M Noda H Ikeuchi K Tsukamoto T Oshima Y Fujiwara N Gondo K Tamura J Utsunomiya T Hashimoto-Tamaoki T Yamamura 2006 Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis J Clin Oncol 24 102 105 (Pubitemid 46630500)
14. A Hansmann C Adolph T Vogel A Unger G Moeslein 2004 High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors Cancer 100 612 620 (Pubitemid 38128287)
15. MC Heinrich GA McArthur GD Demetri H Joensuu P Bono R Herrmann H Hirte S Cresta DB Koslin CL Corless S Dirnhofer AT van Oosterom Z Nikolova S Dimitrijevic JA Fletcher 2006 Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor) J Clin Oncol 24 1195 1203 (Pubitemid 46638818)
16. MC Heinrich H Joensuu GD Demetri CL Corless J Apperley JA Fletcher D Soulieres S Dirnhofer A Harlow A Town A McKinley SG Supple J Seymour L Di Scala A van Oosterom R Herrmann Z Nikolova AG McArthur 2008 Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases Clin Cancer Res 14 2717 2725
17. HS Hosalkar JT Torbert EJ Fox TF Delaney AJ Aboulafia RD Lackman 2008 Musculoskeletal desmoid tumors J Am Acad Orthop Surg 16 188 198
18. AJ Lazar D Tuvin S Hajibashi S Habeeb S Bolshakov E Mayordomo-Aranda CL Warneke D Lopez-Terrada RE Pollock D Lev 2008 Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors Am J Pathol 173 1518 1527
19. D Lev D Kotilingam C Wei MT Ballo GK Zagars PW Pisters AA Lazar SR Patel RS Benjamin RE Pollock 2007 Optimizing treatment of desmoid tumors J Clin Oncol 25 1785 1791 (Pubitemid 46797962)
20. JJ Lewis PJ Boland DH Leung JM Woodruff MF Brennan 1999 The enigma of desmoid tumors Ann Surg 229 866 872 discussion 872-3
21. M Li C Cordon-Cardo WL Gerald J Rosai 1996 Desmoid fibromatosis is a clonal process Hum Pathol 27 939 943 (Pubitemid 26304573)
22. DR Lucas KR Shroyer PJ McCarthy NE Markham M Fujita TE Enomoto 1997 Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation Am J Surg Pathol 21 306 311 (Pubitemid 27120199)
23. J Mace J Sybil Biermann V Sondak C McGinn C Hayes D Thomas L Baker 2002 Response of extraabdominal desmoid tumors to therapy with imatinib mesylate Cancer 95 2373 2379 (Pubitemid 35351145)
24. G Magro E Lanteri G Micali G Paravizzini S Travali S Lanzafame 1997 Myofibroblasts of palmar fibromatosis co-express transforming growth factor-alpha and epidermal growth factor receptor J Pathol 181 213 217 (Pubitemid 27087288)
25. SB Middleton IM Frayling RK Phillips 2000 Desmoids in familial adenomatous polyposis are monoclonal proliferations Br J Cancer 82 827 832 (Pubitemid 30085234)
26. SH Okuno JH Edmonson 2003 Combination chemotherapy for desmoid tumors Cancer 97 1134 1135 (Pubitemid 36173168)
27. SR Patel RS Benjamin 2006 Desmoid tumors respond to chemotherapy: defying the dogma in oncology J Clin Oncol 24 11 12 (Pubitemid 46630487)
28. SR Patel HL Evans RS Benjamin 1993 Combination chemotherapy in adult desmoid tumors Cancer 72 3244 3247 (Pubitemid 23356767)
29. D Rakheja JC Cunningham M Mitui AS Patel GE Tomlinson AG Weinberg 2008 A subset of cranial fasciitis is associated with dysregulation of the Wnt/beta-catenin pathway Mod Pathol 21 11 1330 1336
30. T Saito Y Oda K Kawaguchi K Tanaka S Matsuda S Tamiya Y Iwamoto M Tsuneyoshi 2002 Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan polymerase chain reaction Lab Invest 82 97 103 (Pubitemid 34072650)
31. J Seinfeld BK Kleinschmidt-Demasters S Tayal KO Lillehei 2006 Desmoid-type fibromatoses involving the brachial plexus: treatment options and assessment of c-KIT mutational status J Neurosurg 104 749 756
32. KM Skubitz DR D'Adamo 2007 Sarcoma Mayo Clin Proc 82 1409 1432 (Pubitemid 350060138)
33. KM Skubitz AP Skubitz 2004 Characterization of sarcomas by means of gene expression J Lab Clin Med 144 78 91 (Pubitemid 39119806)
34. KM Skubitz AP Skubitz 2004 Gene expression in aggressive fibromatosis J Lab Clin Med 143 89 98 (Pubitemid 38241560)
35. KM Skubitz H Hamdan RC Thompson Jr 1993 Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas Cancer 72 2963 2969 (Pubitemid 23335041)
36. KM Skubitz S Pambuccian JC Manivel AP Skubitz 2008 Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors J Transl Med 6 23
37. AJ Smith JJ Lewis NB Merchant DH Leung JM Woodruff MF Brennan 2000 Surgical management of intra-abdominal desmoid tumours Br J Surg 87 608 613 (Pubitemid 30261097)
38. S Tejpar F Nollet C Li JS Wunder G Michils P dal Cin E Van Cutsem B Bapat F van Roy JJ Cassiman BA Alman 1999 Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor) Oncogene 18 6615 6620
39. G Wcislo K Szarlej-Wcislo C Szczylik 2007 Control of aggressive fibromatosis by treatment with imatinib mesylate: a case report and review of the literature J Cancer Res Clin Oncol 133 8 533 538 (Pubitemid 46955681)
40. AJ Weiss S Horowitz RD Lackman 1999 Therapy of desmoid tumors and fibromatosis using vinorelbine Am J Clin Oncol 22 193 195 (Pubitemid 30263353)